Cotecna, a global provider of testing, inspection, and certification services, has expanded its international network. The company strengthened its services by acquiring Enerzann Labs, based in Hyderabad.
Enerzann Labs adheres to cGMP standards. It has completed USFDA inspections and holds international accreditations such as ISO 9001:2015 and ISO 17025:2017. These recognitions add to Cotecna's capabilities.
This partnership will make analytical testing services more accessible for the pharmaceutical, biopharma, medical devices, and packaging sectors in India, the USA, Asia Pacific, and the Middle East. The skilled scientists and modern infrastructure in Hyderabad will benefit Cotecna.
India has become a pharmaceutical manufacturing hub in the global healthcare system. This acquisition will help expand Indian pharma products in international markets. It is a strategic move aligned with global supply chain demands and regulations.
Enerzann Labs offers expertise in analytical method development, stability studies, impurity profiling, peptide and oligonucleotide analysis, and regulatory advisory services. These skills position Cotecna as a trusted partner for Indian manufacturers in markets with strict regulatory standards worldwide.
Cotecna is already expanding with companies like Shiva Analyticals and Neotron Pharma. With Enerzann, it aims to become a leader in the Indian life sciences sector, ensuring quality standards from manufacturing to market delivery.
